Findings

What do systematic reviews say?

12 questions · 14 findings · 1 reviews · Gynaecology and Fertility

Sort:Best matchNewest Highest certainty Download CSV

No studies found 9 · 64.3%GRADE not reported 0 · 0%Very low 5 · 35.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Oral vs vaginal administration of oestradiol and dydrogesterone

Uterine volume (cm³) · women with premature ovarian insufficiency (POI) awaiting oocyte donation

2 findings from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low
Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Oral vs vaginal administration of oestradiol and dydrogesterone

Endometrial thickness (mm) · women with premature ovarian insufficiency (POI) awaiting oocyte donation

2 findings from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low
Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Very low

Oral vs vaginal administration of oestradiol and dydrogesterone

Endometrial histology · women with premature ovarian insufficiency (POI) awaiting oocyte donation

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oral vs vaginal administration of oestradiol and dydrogesterone

Uterine perfusion · women with premature ovarian insufficiency (POI) awaiting oocyte donation

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oral vs vaginal administration of oestradiol and dydrogesterone

Reproductive outcomes · women with premature ovarian insufficiency (POI) awaiting oocyte donation

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Oral vs vaginal administration of oestradiol and dydrogesterone

Adverse events · women with premature ovarian insufficiency (POI) awaiting oocyte donation

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Conjugated oral oestrogens vs transdermal 17ß‐estradiol

Uterine volume (cm³) · girls with Turner syndrome who were treated with prepubertal growth hormone

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 12 participants
Very low

Conjugated oral oestrogens vs transdermal 17ß‐estradiol

Endometrial thickness (mm) · girls with Turner syndrome who were treated with prepubertal growth hormone

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Conjugated oral oestrogens vs transdermal 17ß‐estradiol

Endometrial histology · girls with Turner syndrome who were treated with prepubertal growth hormone

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Conjugated oral oestrogens vs transdermal 17ß‐estradiol

Uterine perfusion · girls with Turner syndrome who were treated with prepubertal growth hormone

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Conjugated oral oestrogens vs transdermal 17ß‐estradiol

Reproductive outcomes · girls with Turner syndrome who were treated with prepubertal growth hormone

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Conjugated oral oestrogens vs transdermal 17ß‐estradiol

Adverse events · girls with Turner syndrome who were treated with prepubertal growth hormone

The review found no eligible studies for this question.

1 finding from 1 review

Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found